5th DIA Cell and Gene Therapy Products Symposium in Japan
“Regenerative Medicine from Innovation to Industrialization”
December 10-11, 2020
Day 1: Industrialization of Regenerative Medicines: Basic Concepts of Reliable and Stable Quality Manufacturing
Day 2: Industrialization of Regenerative Medicines: Securing Supply Systems, Issues in Medical Settings, and Trends in Asia
Virtual Meeting (Zoom Webinar)
Since 2016, DIA Japan has been holding a regenerative medicine symposium to find the solutions of key problems faced by companies and academia using constructive discussions of each stage of the process, from research to post-marketing, between public and private sectors.
On Day 1 at the 5th DIA Cell and Gene Therapy Products Symposium in Japan, Kazumi Sawaguchi, Ph.D., Head of Regulatory Affairs Japan (Current Title: Head of Japan Regulatory Affairs and Quality Control) gave a presentation on “Challenge to Comparability Evaluation and Change Control” during Session 3: “Strategy for Comparability Study on Change Management of Cell Therapy Products and Gene Therapy Products”. Additional information about this event is available at DIA Japan.